Effects of leptin and adiponectin on pancreatic β-cell function

Area of Science:

• Endocrinology
• Metabolic Research
• Cell Biology

Background:

• Leptin and adiponectin are key adipokines regulating metabolism and energy balance.
• Beta-cell dysfunction is central to metabolic diseases like type 2 diabetes.
• Understanding adipokine effects on beta cells is crucial for therapeutic development.

Purpose of the Study:

• To comprehensively review the multifaceted effects of leptin and adiponectin on pancreatic beta-cell function.
• To synthesize evidence from diverse study types, including clinical, epidemiological, in vitro, and in vivo research.
• To identify consistencies, inconsistencies, and knowledge gaps regarding these adipokines' roles.

Main Methods:

• Systematic review and meta-analysis of existing literature.
• Analysis of human clinical trials and epidemiological data.
• Evaluation of in vitro and in vivo experimental findings.

Main Results:

• Leptin inhibits ectopic fat, protects beta cells from apoptosis, but suppresses insulin gene expression and secretion.
• Adiponectin enhances insulin secretion and gene expression, and offers antiapoptotic effects, modulated by glucose and insulin resistance.
• Conflicting data exists, highlighting the complexity of adipokine actions on beta cells.

Conclusions:

• Leptin and adiponectin exert complex, sometimes opposing, effects on beta-cell function, insulin secretion, and survival.
• The net impact of these adipokines is context-dependent, influenced by metabolic status.
• Further research is essential to fully elucidate their roles and therapeutic potential in metabolic disorders.